跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

MAB8262B-5

Sigma-Aldrich

Anti-RSV Antibody, fusion protein, all type A, B strains, clone 133-1H

clone 133-1H, Chemicon®, from mouse

别名:

RSV

登录查看公司和协议定价
所有图片(1)

About This Item

UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物来源

mouse

质量水平

300

偶联物

biotin conjugate

抗体形式

purified immunoglobulin

抗体产品类型

primary antibodies

克隆

133-1H, monoclonal

种属反应性

human

制造商/商品名称

Chemicon®

技术

immunofluorescence: suitable

同位素/亚型

IgG2aκ

运输

wet ice

特异性

Directed against the 47-49 kDa Fusion Protein of RSV. Antibody MAB858-1 recognizes both A and B RSV strains.

免疫原

Respiratory Syncytial virus A2

应用

Detect Respiratory Syncytial Virus using this Anti-RSV Antibody, fusion protein, all type A, B strains, clone 133-1H validated for use in IF.
Immunofluorescence

Optimal working dilutions must be determined by the end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral

外形

Biotin conjugated purified immunoglobulin. Liquid in 0.01M PBS, pH=7.1, 0.1% Sodium Azide with 15 mg/mL BSA as stabilizer

储存及稳定性

Store at 2 to 8ºC for up to 12 months from date of receipt. Protect from light.

其他说明

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

法律信息

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

未找到合适的产品？  

试试我们的产品选型工具.

储存分类代码

12 - Non Combustible Liquids

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Megan Levy et al.
PLoS pathogens, 20(5), e1012198-e1012198 (2024-05-13)
Respiratory syncytial virus (RSV) is the most important viral agent of severe pediatric respiratory illness worldwide, but there is no approved pediatric vaccine. Here, we describe the development of the live-attenuated RSV vaccine candidate Min AL as well as engineered
N C Salisch et al.
NPJ vaccines, 4, 54-54 (2019-12-31)
Respiratory Syncytial Virus (RSV) can cause severe respiratory disease, yet a licensed vaccine is not available. We determined the immunogenicity of two homologous and one heterologous intramuscular prime-boost vaccination regimens using replication-incompetent adenoviral vectors of human serotype 26 and 35

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门